Literature DB >> 19210225

The cellular immune response plays an important role in protecting against dengue virus in the mouse encephalitis model.

Lázaro Gil1, Carlos López, Aracelys Blanco, Laura Lazo, Jorge Martín, Iris Valdés, Yaremis Romero, Yassel Figueroa, Gerardo Guillén, Lisset Hermida.   

Abstract

For several years, researchers have known that the generation of neutralizing antibodies is a prerequisite for attaining adequate protection against dengue virus. Nevertheless, the cellular immune response is the principal arm of the adaptive immune system against non-cytopathic viruses such as dengue, as once the virus enters into the cell it is necessary to destroy it to eliminate the virus. To define the role of the cellular immune response in the protection against dengue, we selected the mouse encephalitis model. Mice were immunized with a single dose of infective dengue 2 virus and different markers of both branches of the induced adaptive immunity were measured. Animals elicited a broad antibody response against the four dengue virus serotypes, but neutralizing activity was only detected against the homologous serotype. On the other hand, the splenocytes of the infected animals strongly proliferated after in vitro stimulation with the homologous virus, and specifically the CD8 T-cell subset was responsible for the secretion of the cytokine IFN-gamma. Finally, to define the role of T cells in in vivo protection, groups of animals were inoculated with the depleting monoclonal antibodies anti-CD4 or anti-CD8. Only depletion with anti-CD8 decreased to 50% the level of protection reached in the non-depleted mice. The present work constitutes the first report defining the role of the cellular immune response in protection against dengue virus in the mouse model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19210225     DOI: 10.1089/vim.2008.0063

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  17 in total

1.  The chimeric protein domain III-capsid of dengue virus serotype 2 (DEN-2) successfully boosts neutralizing antibodies generated in monkeys upon infection with DEN-2.

Authors:  Iris Valdés; Lázaro Gil; Yaremis Romero; Jorge Castro; Pedro Puente; Laura Lazo; Ernesto Marcos; María G Guzmán; Gerardo Guillén; Lisset Hermida
Journal:  Clin Vaccine Immunol       Date:  2011-01-05

2.  Dengue virus specific dual HLA binding T cell epitopes induce CD8+ T cell responses in seropositive individuals.

Authors:  Joseph D Comber; Aykan Karabudak; Xiaofang Huang; Paolo A Piazza; Ernesto T A Marques; Ramila Philip
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.

Authors:  Rosa Ramírez; Rosabel Falcón; Alienys Izquierdo; Angélica García; Mayling Alvarez; Ana Beatriz Pérez; Yudira Soto; Mayra Muné; Emiliana Mandarano da Silva; Oney Ortega; Ronaldo Mohana-Borges; María G Guzmán
Journal:  Virus Genes       Date:  2014-05-23       Impact factor: 2.332

Review 4.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

5.  The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2.

Authors:  Lázaro Gil; Ernesto Marcos; Alienys Izquierdo; Laura Lazo; Iris Valdés; Peris Ambala; Lucy Ochola; Rikoi Hitler; Edith Suzarte; Mayling Álvarez; Prisilla Kimiti; James Ndung'u; Thomas Kariuki; María Guadalupe Guzmán; Gerardo Guillén; Lisset Hermida
Journal:  Immunol Cell Biol       Date:  2014-09-02       Impact factor: 5.126

6.  Intracerebral infection with dengue-3 virus induces meningoencephalitis and behavioral changes that precede lethality in mice.

Authors:  Debora C G Amaral; Milene A Rachid; Marcia C Vilela; Roberta D L Campos; Gustavo P Ferreira; David H Rodrigues; Norinne Lacerda-Queiroz; Aline S Miranda; Vivian V Costa; Marco A Campos; Erna G Kroon; Mauro M Teixeira; Antonio L Teixeira
Journal:  J Neuroinflammation       Date:  2011-03-09       Impact factor: 8.322

7.  Phenotypic characterization of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome.

Authors:  Anne Tuiskunen; Maria Wahlström; Jakob Bergström; Philippe Buchy; Isabelle Leparc-Goffart; Ake Lundkvist
Journal:  Virol J       Date:  2011-08-11       Impact factor: 4.099

8.  IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner.

Authors:  Caio T Fagundes; Vivian V Costa; Daniel Cisalpino; Flávio A Amaral; Patrícia R S Souza; Rafael S Souza; Bernhard Ryffel; Leda Q Vieira; Tarcília A Silva; Alena Atrasheuskaya; George Ignatyev; Lirlândia P Sousa; Danielle G Souza; Mauro M Teixeira
Journal:  PLoS Negl Trop Dis       Date:  2011-12-20

Review 9.  Current progress in dengue vaccines.

Authors:  Shu-Wen Wan; Chiou-Feng Lin; Shuying Wang; Yu-Hung Chen; Trai-Ming Yeh; Hsiao-Sheng Liu; Robert Anderson; Yee-Shin Lin
Journal:  J Biomed Sci       Date:  2013-06-13       Impact factor: 8.410

10.  Potential biomarkers for the clinical prognosis of severe dengue.

Authors:  Mayara Marques Carneiro da Silva; Laura Helena Vega Gonzales Gil; Ernesto Torres de Azevedo Marques; Carlos Eduardo Calzavara-Silva
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-09       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.